Activation of the Raf/MAP Kinase Cascade by the Ras-related Protein TC21 is Required for the TC21-mediated Transformation of NIH 3T3 Cells

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1999 Mar 4

PMID 10064593

Citations 26

Authors

M Rosario

H F PATERSON

C J Marshall

Affiliations

Soon will be listed here.

Abstract

TC21 is a member of the Ras superfamily of small GTP-binding proteins and, like Ras, has been implicated in the regulation of growth-stimulating pathways. Point mutations introduced into TC21 based on equivalent H-Ras oncogenic mutations are transforming in cultured cells, and oncogenic mutations in TC21 have been isolated from several human tumours. The mechanism of TC21 signalling in transformation is poorly understood. While activation of the serine/threonine kinases Raf-1 and B-Raf has been implicated in signalling pathways leading to transformation by H-Ras, it has been argued that TC21 does not activate Raf-1 or B-Raf. Since the Raf-signalling pathway is important in transformation by other Ras proteins, we assessed whether the Raf pathway is important to transformation by TC21. Raf-1 and B-Raf are constitutively active in TC21-transformed cells and the ERK/MAPK cascade is required for the maintenance of the transformed state. We demonstrate that oncogenic V23 TC21, like Ras, interacts with Raf-1 and B-Raf (but not with A-Raf), resulting in the translocation of the Raf proteins to the plasma membrane and in their activation. Furthermore, using point mutations in the effector loop of TC21, we show that the interaction of TC21 with Raf-1 is crucial for transformation.

Citing Articles

Transfection of Sponge Cells and Intracellular Localization of Cancer-Related MYC, RRAS2, and DRG1 Proteins.

Dominko K, Talajic A, Radic M, Vidacek N, Vlahovicek K, Herak Bosnar M Mar Drugs. 2023; 21(2).

PMID: 36827160 PMC: 9964533. DOI: 10.3390/md21020119.

Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors.

Clavain L, Fernandez-Pisonero I, Movilla N, Lorenzo-Martin L, Nieto B, Abad A Oncogene. 2022; 42(5):389-405.

PMID: 36476833 PMC: 9883167. DOI: 10.1038/s41388-022-02563-9.

R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells.

Weber S, Brossier N, Prechtl A, Barnes S, Wilson L, Brosius S Cell Commun Signal. 2021; 19(1):95.

PMID: 34530870 PMC: 8447793. DOI: 10.1186/s12964-021-00773-4.

TC21/RRas2 regulates glycoprotein VI-FcRγ-mediated platelet activation and thrombus stability.

Janapati S, Wurtzel J, Dangelmaier C, Manne B, Bhavanasi D, Kostyak J J Thromb Haemost. 2018; .

PMID: 29883056 PMC: 6286703. DOI: 10.1111/jth.14197.

R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.

Sanz-Rodriguez M, Gruart A, Escudero-Ramirez J, de Castro F, Delgado-Garcia J, Wandosell F J Neurosci. 2018; 38(22):5096-5110.

PMID: 29720552 PMC: 6705947. DOI: 10.1523/JNEUROSCI.3364-17.2018.

References

Evan G, LEWIS G, Ramsay G, Bishop J . Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985; 5(12):3610-6. PMC: 369192. DOI: 10.1128/mcb.5.12.3610-3616.1985. View

Barbacid M . ras genes. Annu Rev Biochem. 1987; 56:779-827. DOI: 10.1146/annurev.bi.56.070187.004023. View

Drivas G, Shih A, Coutavas E, Rush M, DEustachio P . Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. Mol Cell Biol. 1990; 10(4):1793-8. PMC: 362288. DOI: 10.1128/mcb.10.4.1793-1798.1990. View

Ahn N, Seger R, Bratlien R, Diltz C, Tonks N, KREBS E . Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J Biol Chem. 1991; 266(7):4220-7. View

Payne D, Rossomando A, Martino P, Erickson A, Her J, Shabanowitz J . Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 1991; 10(4):885-92. PMC: 452730. DOI: 10.1002/j.1460-2075.1991.tb08021.x. View

Leevers S, Marshall C . Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 1992; 11(2):569-74. PMC: 556488. DOI: 10.1002/j.1460-2075.1992.tb05088.x. View

Williams N, Roberts T, Li P . Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase. Proc Natl Acad Sci U S A. 1992; 89(7):2922-6. PMC: 48775. DOI: 10.1073/pnas.89.7.2922. View

Nakielny S, Cohen P, Wu J, Sturgill T . MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase. EMBO J. 1992; 11(6):2123-9. PMC: 556679. DOI: 10.1002/j.1460-2075.1992.tb05271.x. View

Howe L, Leevers S, Gomez N, Nakielny S, Cohen P, Marshall C . Activation of the MAP kinase pathway by the protein kinase raf. Cell. 1992; 71(2):335-42. DOI: 10.1016/0092-8674(92)90361-f. View

10.

Albright C, Giddings B, Liu J, Vito M, Weinberg R . Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J. 1993; 12(1):339-47. PMC: 413211. DOI: 10.1002/j.1460-2075.1993.tb05662.x. View

11.

Van Aelst L, Barr M, MARCUS S, Polverino A, Wigler M . Complex formation between RAS and RAF and other protein kinases. Proc Natl Acad Sci U S A. 1993; 90(13):6213-7. PMC: 46898. DOI: 10.1073/pnas.90.13.6213. View

12.

Traverse S, Cohen P, PATERSON H, Marshall C, Rapp U, Grand R . Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Oncogene. 1993; 8(11):3175-81. View

13.

Alessi D, Saito Y, Campbell D, Cohen P, Sithanandam G, Rapp U . Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 1994; 13(7):1610-9. PMC: 394991. DOI: 10.1002/j.1460-2075.1994.tb06424.x. View

14.

Graham S, Cox A, Drivas G, Rush M, DEustachio P, Der C . Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cell Biol. 1994; 14(6):4108-15. PMC: 358776. DOI: 10.1128/mcb.14.6.4108-4115.1994. View

15.

Cowley S, PATERSON H, Kemp P, Marshall C . Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 1994; 77(6):841-52. DOI: 10.1016/0092-8674(94)90133-3. View

16.

Fabian J, Vojtek A, Cooper J, Morrison D . A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function. Proc Natl Acad Sci U S A. 1994; 91(13):5982-6. PMC: 44121. DOI: 10.1073/pnas.91.13.5982. View

17.

White M, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M . Multiple Ras functions can contribute to mammalian cell transformation. Cell. 1995; 80(4):533-41. DOI: 10.1016/0092-8674(95)90507-3. View

18.

Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A . The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature. 1995; 375(6532):554-60. DOI: 10.1038/375554a0. View

19.

Marais R, Light Y, PATERSON H, Marshall C . Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 1995; 14(13):3136-45. PMC: 394375. DOI: 10.1002/j.1460-2075.1995.tb07316.x. View

20.

Dudley D, Pang L, Decker S, Bridges A, Saltiel A . A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995; 92(17):7686-9. PMC: 41210. DOI: 10.1073/pnas.92.17.7686. View